RR DONNELLEY & SONS CO (RRD)

Common Stock

10.84  0 (0%)

After market: 10.84 0 (0%)

Fundamental Rating

2

Taking everything into account, RRD scores 2 out of 10 in our fundamental rating. RRD was compared to 85 industry peers in the Commercial Services & Supplies industry. RRD has a bad profitability rating. Also its financial health evaluation is rather negative. RRD is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year RRD was profitable.
The reported net income has been mixed in the past 5 years: RRD reported negative net income in multiple years.
In the past 5 years RRD always reported a positive cash flow from operatings.

1.2 Ratios

Industry RankSector Rank
ROA 0.12%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 3.96%
PM (TTM) 0.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

RRD has more shares outstanding than it did 1 year ago.
The debt/assets ratio for RRD has been reduced compared to a year ago.

2.2 Solvency

RRD has an Altman-Z score of 1.08. This is a bad value and indicates that RRD is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of -8.21 indicates that RRD is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -8.21
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

RRD has a Current Ratio of 1.37. This is a normal value and indicates that RRD is financially healthy and should not expect problems in meeting its short term obligations.
RRD has a Quick Ratio of 1.10. This is a normal value and indicates that RRD is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.1

4

3. Growth

3.1 Past

RRD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.36%.
The earnings per share for RRD have been decreasing by -25.36% on average. This is quite bad
The Revenue has been growing slightly by 4.14% in the past year.
Measured over the past years, RRD shows a decrease in Revenue. The Revenue has been decreasing by -6.19% on average per year.
EPS 1Y (TTM)2.36%
EPS 3Y22.92%
EPS 5Y-25.36%
EPS growth Q2Q-18.31%
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-4.52%
Revenue growth 5Y-6.19%
Revenue growth Q2Q2.12%

3.2 Future

Based on estimates for the next years, RRD will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.12% on average per year.
RRD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.23% yearly.
EPS Next Y1.78%
EPS Next 2Y16.66%
EPS Next 3Y22.5%
EPS Next 5Y17.12%
Revenue Next Year2.47%
Revenue Next 2Y3.46%
Revenue Next 3Y4.14%
Revenue Next 5Y5.23%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.34, which indicates a very decent valuation of RRD.
RRD is valuated cheaply when we compare the Price/Earnings ratio to 28.11, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.19, the valuation of RRD can be described as very reasonable.
RRD is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.34
Fwd PE 8.19

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.11

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RRD does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as RRD's earnings are expected to grow with 22.50% in the coming years.
PEG (NY)4.69
PEG (5Y)N/A
EPS Next 2Y16.66%
EPS Next 3Y22.5%

1

5. Dividend

5.1 Amount

RRD has a yearly dividend return of 0.33%, which is pretty low.
Compared to an average S&P500 Dividend Yield of 2.40, RRD's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.33%

5.2 History

RRD has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DP0%
EPS Next 2Y16.66%
EPS Next 3Y22.5%

RR DONNELLEY & SONS CO

NYSE:RRD (2/25/2022, 7:08:22 PM)

After market: 10.84 0 (0%)

10.84

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap815.28M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.33%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 8.34
Fwd PE 8.19
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.12%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 3.96%
PM (TTM) 0.07%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity -8.21
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.37
Quick Ratio 1.1
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)2.36%
EPS 3Y22.92%
EPS 5Y
EPS growth Q2Q
EPS Next Y1.78%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-4.52%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y